XML 32 R19.htm IDEA: XBRL DOCUMENT
v3.21.2

Financial Instruments | 6 Months Ended
--- | ---
Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Financial Instruments [Text Block] | Financial Instruments We enter into derivative instruments primarily for risk management purposes, including derivatives designated as hedging instruments and those utilized as economic hedges. We operate internationally and, in the normal course of business, are exposed to fluctuations in interest rates, foreign exchange rates and commodity prices. These fluctuations can increase the costs of financing, investing and operating the business. We have used derivative instruments, including swaps, forward contracts and options, to manage certain foreign currency, interest rate and commodity price exposures. The aggregate notional amount of our outstanding foreign currency hedges was $9.3 billion and $11.6 billion at June 30, 2021 and December 31, 2020, respectively. The following table summarizes the fair value and presentation in the Condensed Consolidated Balance Sheet for derivative instruments as of June 30, 2021 and December 31, 2020:
(dollars in millions) | Balance Sheet Location | June 30, 2021 |  | December 31, 2020
Derivatives designated as hedging instruments: |  |  |  |
Foreign exchange contracts | Other assets, current | $ | 224 |  |  | $ | 197 |
| Other accrued liabilities | 70 |  |  | 66 |
Derivatives not designated as hedging instruments: |  |  |  |
Foreign exchange contracts | Other assets, current | $ | 23 |  |  | $ | 44 |
| Other accrued liabilities | 25 |  |  | 32 |
The effect of cash flow hedging relationships on Accumulated other comprehensive income (loss) and on the Condensed Consolidated Statement of Operations for the quarters and six months ended June 30, 2021 and 2020 are presented in the table below. The amounts of gain or loss are attributable to foreign exchange contract activity and are generally recorded as a component of Product sales when reclassified from Accumulated other comprehensive income (loss).
| Quarter Ended June 30, |  | Six Months Ended June 30,
(dollars in millions) | 2021 |  | 2020 |  | 2021 |  | 2020
Gain (loss) recorded in Accumulated other comprehensive loss | $ | 108 |  |  | $ | 188 |  |  | $ | 62 |  |  | $ | (215) |
(Gain) loss reclassified from Accumulated other comprehensive loss into Product sales | (20) |  |  | 27 |  |  | (34) |  |  | 56 |
The Company utilizes the critical terms match method in assessing derivatives for hedge effectiveness. Accordingly, the hedged items and derivatives designated as hedging instruments are highly effective. As of June 30, 2021, we have €500 million of euro-denominated long-term debt outstanding, which qualifies as a net investment hedge against our investments in European businesses, which is deemed to be effective. Assuming current market conditions continue, $53 million of pre-tax gains are expected to be reclassified from Accumulated other comprehensive loss into Product sales to reflect the fixed prices obtained from foreign exchange hedging within the next 12 months. At June 30, 2021, all derivative contracts accounted for as cash flow hedges will m ature by January 2028. The effect of derivatives not designated as hedging instruments within Other income, net, on the Condensed Consolidated Statement of Operations was as follows:
| Quarter Ended June 30, |  | Six Months Ended June 30,
(dollars in millions) | 2021 |  | 2020 |  | 2021 |  | 2020
Gain (loss) on non-designated foreign exchange contracts | $ | — |  |  | $ | 10 |  |  | $ | (8) |  |  | $ | (29) |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 5 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration